Proceedings of 1st International Conference on Health Sciences and Biotechnology (ICHB 2021)

<Previous Article In Volume
Next Article In Volume>

Potential Forkhead Box O 3a as Prognostic Biomarker in Prostate Cancer

Authors
Anandia Putriyuni1, 2, *, Meta Z. Oktora2, Nurwiyeni Nurwiyeni2, Tofrizal Tofrizal3
1Rasidin Hospital, Padang, Indonesia
2Department of Anatomical Pathology, Faculty of Medicine, Baiturrahmah University, Padang, Indonesia
3Department of Anatomical Pathology, Faculty of Medicine, Andalas University, Padang, Indonesia
*Corresponding author. Email: anandia_putriyuni@yahoo.com
Corresponding Author
Anandia Putriyuni
Available Online 8 March 2022.
DOI
10.2991/ahsr.k.220303.004How to use a DOI?
Keywords
Forkhead Box O 3a; Prognostic Biomarker; Prostate Cancer
Abstract

Background: Forkhead box O 3a is a transcription factor, a member of the Forkhead box O family. It has a crucial role in both oncogenesis and tumor suppression. Cellular localization and phosphorylation status are considered to be prognostic factors for cancers. Loss of Forkhead box O 3a was found in various cancers. However, its mechanism in prostate cancer remains unclear. Objective: To analyze Forkhead box O 3a as prognostic biomarker potential in prostate cancer. Methods: This analytical study was done with a cross-sectional design. The population was all cases of primary prostate cancer from the Anatomical Pathology Department in West Sumatera. The sample was 56 slides and paraffin blocks with adequate tumor tissue. Hematoxylin and eosin-stained slides were evaluated to review Gleason score. The immunohistochemistry staining of Forkhead box O 3a on paraffin blocks was carried out to analyze protein expression semi-quantitatively. Positive expression was moderate to strong interpretation. Results: The highest proportion of prostate cancer was high-grade Gleason score (8-10) 76.79% cases. The positive Forkhead box O 3a expression on tumor cells was 51.79%, predominantly in the cytoplasm. The negative expression in the high-grade Gleason score was more than positive. Statistically, these results showed a negative significant correlation of Forkhead box O 3a expression and Gleason score (p=0.038). Conclusion: Forkhead box O 3a was likely to be deactivated in prostate cancer. Abstain expression in nuclear, but overexpression in the cytoplasm of tumor cells induces loss of tumor suppression function. Thus, Forkhead box O 3a has potential as a prognostic biomarker for prostate cancer.

Copyright
© 2022 The Authors. Published by Atlantis Press International B.V.
Open Access
This is an open access article under the CC BY-NC license.

Download article (PDF)

<Previous Article In Volume
Next Article In Volume>
Volume Title
Proceedings of 1st International Conference on Health Sciences and Biotechnology (ICHB 2021)
Series
Advances in Health Sciences Research
Publication Date
8 March 2022
ISBN
10.2991/ahsr.k.220303.004
ISSN
2468-5739
DOI
10.2991/ahsr.k.220303.004How to use a DOI?
Copyright
© 2022 The Authors. Published by Atlantis Press International B.V.
Open Access
This is an open access article under the CC BY-NC license.

Cite this article

risenwbib
TY  - CONF
AU  - Anandia Putriyuni
AU  - Meta Z. Oktora
AU  - Nurwiyeni Nurwiyeni
AU  - Tofrizal Tofrizal
PY  - 2022
DA  - 2022/03/08
TI  - Potential Forkhead Box O 3a as Prognostic Biomarker in Prostate Cancer
BT  - Proceedings of 1st International Conference on Health Sciences and Biotechnology (ICHB 2021)
PB  - Atlantis Press
SP  - 19
EP  - 23
SN  - 2468-5739
UR  - https://doi.org/10.2991/ahsr.k.220303.004
DO  - 10.2991/ahsr.k.220303.004
ID  - Putriyuni2022
ER  -